Indication

Erysipelothrix endocarditis

Erysipelothrix endocarditis is a rare, severe bacterial infection of the endocardium primarily caused by the zoonotic Gram-positive bacillus *Erysipelothrix rhusiopathiae*. Read more about Erysipelothrix endocarditis

15 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Erysipelothrix endocarditis therapies.

Showing 10–15 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Erysipelothrix endocarditis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Erysipelothrix endocarditis.

Erysipelothrix endocarditis is a rare, severe bacterial infection of the endocardium primarily caused by the zoonotic Gram-positive bacillus *Erysipelothrix rhusiopathiae*.

It most frequently affects adults with occupational exposure to animals, poultry, swine, or marine life, such as farmers, butchers, and fishermen.

Pathophysiologically, hematogenous dissemination—often following cutaneous inoculation or an erysipeloid skin lesion—leads to valvular seeding, exhibiting a marked predilection for native left-sided heart valves, particularly the aortic valve.

Clinically, the disease presents as an aggressive endovascular infection characterized by persistent bacteremia, destructive valvular vegetation, and acute heart failure, carrying a significant risk of systemic embolization and a high mortality rate.

Personalize your experience

Follow Erysipelothrix endocarditis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it